SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Whyte J, Greenan E. Drug usage and adverse drug reactions in paediatric patients. Acta Paediatr Scand 1977; 66: 76775.
  • 2
    Mitchell AA, Goldman P, Shapiro S, Slone D. Drug utilization and reported adverse reactions in hospitalized children. Am J Epidemiol 1979; 110: 196204.
  • 3
    Menniti-Ippolito G, Raschetti R, Da CR, Giaquinto C, Cantarutti L. Active monitoring of adverse drug reactions in children. Italian Paediatric Pharmacosurveillance MultiCentre Group. Lancet 2000; 355: 16134.
  • 4
    Le J, Nguyen T, Law AV, Hodding J. Adverse drug reactions among children over a 10-year period. Pediatrics 2006; 118: 55562.
  • 5
    Mitchell AA, Lacouture PG, Sheehan JE, Kauffman RE, Shapiro S. Adverse drug reactions in children leading to hospital admission. Pediatrics 1988; 82: 249.
  • 6
    Martinez-Mir I, Garcia-Lopez M, Palop V, Ferrer JM, Rubio E, Morales-Olivas FJ. A prospective study of adverse drug reactions in hospitalized children. Br J Clin Pharmacol 1999; 47: 6818.
  • 7
    Dos Santos DB, Coelho HL. Adverse drug reactions in hospitalized children in Fortaleza, Brazil. Pharmacoepidemiol Drug Saf 2006; 15: 63540.
  • 8
    Fattahi F, Pourpak Z, Moin M, Kazemnejad A, Khotaei GT, Mamishi S, Siadati A, Tabatabaei P. Adverse drug reactions in hospitalized children in a department of infectious diseases. J Clin Pharmacol 2005; 45: 13138.
  • 9
    Buajordet I, Wesenberg F, Brors O, Langslet A. Adverse drug events in children during hospitalization and after discharge in a Norwegian university hospital. Acta Paediatr 2002; 91: 8894.
  • 10
    Jonville-Bera AP, Giraudeau B, Blanc P, Beau-Salinas F, Autrec-Leca E. Frequency of adverse drug reactions in children: a prospective study. Br J Clin Pharmacol 2002; 53: 20710.
  • 11
    Cirko-Begovic A, Vrhovac B, Bakran I. Intensive monitoring of adverse drug reactions in infants and preschool children. Eur J Clin Pharmacol 1989; 36: 635.
  • 12
    Sanz E, Boada J. Adverse drug reactions in paediatric outpatients. Int J Clin Pharmacol Res 1987; 7: 16972.
  • 13
    Kramer MS, Hutchinson TA, Flegel KM, Naimark L, Contardi R, Leduc DG. Adverse drug reactions in general pediatric outpatients. J Pediatr 1985; 106: 30510.
  • 14
    Kurth BM, Kamtsiuris P, Hölling H, Schlaud M, Dölle R, Ellert U, Kahl H, Knopf H, Lange M, Mensink GB, Neuhauser H, Rosario AS, Scheidt-Nave C, Schenk L, Schlack R, Stolzenberg H, Thamm M, Thierfelder W, Wolf U. The challenge of comprehensively mapping children's health in a nation-wide health survey: design of the German KiGGS Study. BMC Public Health 2008; 8: 196.
  • 15
    Impicciatore P, Choonara I, Clarkson A, Provasi D, Pandolfini C, Bonati M. Incidence of adverse drug reactions in paediatric in/out-patients: a systematic review and meta-analysis of prospective studies. Br J Clin Pharmacol 2001; 52: 7783.
  • 16
    Clavenna A, Bonati M. Adverse drug reactions in childhood: a review of prospective studies and safety alerts. Arch Dis Child 2009; 94: 7248.
  • 17
    Weiss J, Krebs S, Hoffmann C, Werner U, Neubert A, Brune K, Rascher W. Survey of adverse drug reactions on a pediatric ward: a strategy for early and detailed detection. Pediatrics 2002; 110: 2547.
  • 18
    Neubert A, Dormann H, Weiss J, Egger T, Criegee-Rieck M, Rascher W, Brune K, Hinz B. The impact of unlicensed and off-label drug use on adverse drug reactions in paediatric patients. Drug Saf 2004; 27: 105967.
  • 19
    Neubert A, Dormann H, Weiss J, Criegee-Rieck M, Ackermann A, Levy M, Brune K, Rascher W. Are computerised monitoring systems of value to improve pharmacovigilance in paediatric patients? Eur J Clin Pharmacol 2006; 62: 95965.
  • 20
    Haffner S, Von LN, Wirth S, Thurmann PA. Detecting adverse drug reactions on paediatric wards: intensified surveillance versus computerised screening of laboratory values. Drug Saf 2005; 28: 45364.
  • 21
    Lewis MA, Kuhl-Habich D, Von Rosen J. Drug use and adverse event monitoring in German children. Int J Clin Pharmacol Ther 2001; 39: 50712.
  • 22
    Kamtsiuris P, Lange M, Schaffrath RA. Der Kinder- und Jugendgesundheitssurvey (KiGGS): Stichprobendesign, Response und Nonresponse-Analyse [The German Health Interview and Examination Survey for Children and Adolescents (KiGGS): sample design, response and non-response analysis]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50: 54756.
  • 23
    Knopf H. Arzneimittelanwendung bei Kindern und Jugendlichen. Erfassung und erste Ergebnisse beim Kinder- und Jugendgesundheitssurvey (KiGGS) [Medicine use in children and adolescents. Data collection and first results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50: 86370.
  • 24
    Winkler J, Stolzenberg H. [Social class index in the Federal Health Survey]. Gesundheitswesen 1999; 61: S17883.
  • 25
    Schenk L, Ellert U, Neuhauser H. [Children and adolescents in Germany with a migration background. Methodical aspects in the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2007; 50: 5909.
  • 26
    Gesetz über den Verkehr mit Arzneimitteln (Arzneimittelgesetz – AMG) Arzneimittelgesetz in der Fassung der Bekanntmachung vom 12. Dezember 2005 (BGBl. I S. 3394), das durch Artikel 1 der Verordnung vom 28. September 2009 (BGBl. I S. 3172) geändert worden ist. Berlin: Bundesministerium der Justiz; 2009. Available at http://www.gesetze-im-internet.de/amg_1976/BJNR024480976.html
  • 27
    WIdO, GKV-Arzneimittelindex im Wissenschaftlichen Institut der AOK (WIdO). Anatomisch-Therapeutisch-Chemische-Klassifikation Mit Tagesdosen Amtliche Fassung Des ATC-Index Mit DDD-Angaben Für Die Bundesrepublik Deutschland Im Jahr 2007. Köln: Deutsches Institut für Medizinische Dokumentation und Information (DIMDI), 2009.
  • 28
    Du Y, Knopf H. Paediatric homoeopathy in Germany: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS). Pharmacoepidemiol Drug Saf 2009; 18: 3709.
  • 29
    WHO. International Statistical Classification of Diseases and Health Related Problems (The) ICD-10, 2nd edn. Geneva: World Health Organisation, 2009.
  • 30
    Journot V, Tabuteau S, Collin F, Molina JM, Chene G, Rancinan C. About the necessity to manage events coded with MedDRA prior to statistical analysis: proposal of a strategy with application to a randomized clinical trial, ANRS 099 ALIZE. Contemp Clin Trials 2008; 29: 95101.
  • 31
    MedDRA MSSO Comment on the Primary System Organ Class (SOC) Allocation in MedDRA. MSSO-DI-9745-1.0.0. 6 August 2007. Available at http://www.meddramsso.com/files_acrobat/Primary_SOC_Allocation_in_MedDRA.pdf
  • 32
    Horen B, Montastruc JL, Lapeyre-Mestre M. Adverse drug reactions and off-label drug use in paediatric outpatients. Br J Clin Pharmacol 2002; 54: 66570.
  • 33
    Kidon MI, See Y. Adverse drug reactions in Singaporean children. Singapore Med J 2004; 45: 5747.
  • 34
    Kimland E, Rane A, Ufer M, Panagiotidis G. Paediatric adverse drug reactions reported in Sweden from 1987 to 2001. Pharmacoepidemiol Drug Saf 2005; 14: 4939.
  • 35
    Bates DW, Miller EB, Cullen DJ, Burdick L, Williams L, Laird N, Petersen LA, Small SD, Sweitzer BJ, Vander Vliet M, Leape LL. Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study Group. Arch Intern Med 1999; 159: 255360.
  • 36
    Du Y, Knopf H. Self-medication among children and adolescents in Germany: results of the National Health Survey for Children and Adolescents (KiGGS). Br J Clin Pharmacol 2009; 68: 599608.
  • 37
    Sharfstein JM, North M, Serwint JR. Over the counter but no longer under the radar – pediatric cough and cold medications. N Engl J Med 2007; 357: 23214.
  • 38
    Morales-Olivas FJ, Martinez-Mir I, Ferrer JM, Rubio E, Palop V. Adverse drug reactions in children reported by means of the yellow card in Spain. J Clin Epidemiol 2000; 53: 107680.
  • 39
    Stewart D, Helms P, McCaig D, Bond C, McLay J. Monitoring adverse drug reactions in children using community pharmacies: a pilot study. Br J Clin Pharmacol 2005; 59: 67783.
  • 40
    Schirm E, Tobi H, Van Puijenbroek EP, Monster-Simons MH, De Jong-Van den Berg LT. Reported adverse drug reactions and their determinants in Dutch children outside the hospital. Pharmacoepidemiol Drug Saf 2004; 13: 15965.
  • 41
    Bourgeois FT, Mandl KD, Valim C, Shannon MW. Pediatric adverse drug events in the outpatient setting: an 11-year national analysis. Pediatrics 2009; 124: e74450.
  • 42
    Blenkinsopp A, Wilkie P, Wang M, Routledge PA. Patient reporting of suspected adverse drug reactions: a review of published literature and international experience. Br J Clin Pharmacol 2007; 63: 14856.
  • 43
    Oshikoya KA, Senbanjo IO, Njokanma OF. Parental reporting of suspected adverse drug reactions in children in Lagos, Nigeria. Arch Dis Child 2009; 94: 46973.